On World Tuberculosis (TB) Day 2025, the World Health Organization (WHO) has called for immediate and sustained action to combat the persistent global TB epidemic. Despite advances in treatment and prevention, TB remains one of the world’s deadliest infectious diseases, with an estimated 10.6 million new cases and 1.3 million deaths in 2024 alone.
A Global Health Crisis: TB’s Continued Threat
WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized that while progress has been made, the world is not moving fast enough to eradicate TB. “We have the tools, but we need stronger political commitment, increased funding, and innovative approaches to reach those most vulnerable,” he said in a statement.
According to the WHO Global TB Report 2025, drug-resistant TB is a growing concern, with nearly half a million cases of multidrug-resistant TB (MDR-TB) reported last year. Countries with weak healthcare systems, high poverty levels, and limited access to diagnostics remain the most affected.
Challenges in Diagnosis and Treatment
One of the major barriers to TB eradication is delayed diagnosis. WHO data shows that approximately 40% of people with TB go undiagnosed or receive inadequate treatment. The lack of access to rapid molecular testing and the stigma surrounding the disease continue to hinder early detection.
Dr. Aisha Bello, a TB specialist based in Lagos, Nigeria, highlighted the urgent need for investment in diagnostic technology. “If we can improve access to testing, especially in rural and underserved areas, we can detect and treat TB much earlier, preventing its spread,” she stated.
While TB treatment is available, adherence remains a challenge. Standard treatment for drug-sensitive TB lasts six months, while MDR-TB treatment can extend beyond two years. WHO has urged governments to strengthen support systems for patients, including nutritional aid and mental health services, to improve treatment completion rates.
Funding Gaps Threaten TB Response
Despite commitments from global health organizations and governments, TB programs remain underfunded. The Stop TB Partnership estimates that an additional $5 billion annually is needed to close the funding gap for research, diagnostics, and treatment expansion.
International donor support, particularly from the Global Fund to Fight AIDS, Tuberculosis, and Malaria, has been crucial in many low-income countries. However, funding shortfalls have led to disruptions in TB services, worsening the crisis in high-burden countries.
The Role of Innovation and Collaboration
WHO has called on countries to scale up investments in TB vaccine research, with several promising candidates in late-stage trials. The potential for a more effective TB vaccine could significantly alter the trajectory of the disease, reducing infection rates and transmission.
Additionally, digital health technologies, such as AI-assisted diagnostics and mobile treatment adherence monitoring, are being explored as potential game-changers in the fight against TB.
Urgent Call for Action
As World TB Day 2025 is observed under the theme “Yes! We Can End TB”, WHO is urging nations to recommit to the goal of ending TB by 2030, as outlined in the United Nations Sustainable Development Goals (SDGs). The organization has called for stronger political leadership, increased domestic funding, and a renewed focus on vulnerable populations.
“TB is preventable, treatable, and curable. With the right investments and policies, we can make TB history,” Dr. Tedros concluded.
As the world grapples with other health challenges, experts stress that TB should not be overlooked. The fight against TB requires urgent, coordinated action to prevent millions of avoidable deaths and build a healthier future for all.
